Abstract
Credit This lesson is good for 0.2 CE units, with a passing grade of 70%. Goal The goal of this program is to inform the participant about common types of malignant gliomas and to discuss new treatment modalities. Objectives At the completion of this program the participant will be able to: 1. Identify the standard types of treatment for primary brain tumors 2. Explain the pharmacology of temozolomide and irinotecan 3. List the most common adverse effects associated with temozolomide and irinotecan 4. Determine appropriate monitoring and provide dosing adjustments
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
